El plasma Aβ42/40 predice la progresión de las exploraciones PET de Aβ-amiloide negativo a positivo

Azadeh Feizpour1, Vincent Doré2, Pierrick Bourgeat3

  • 1Florey Institute of Neuroscience and Mental Health, The University of Melbourne, 30 Royal Parade, Parkville, VIC, 3052, Australia; Department of Molecular Imaging & Therapy, Austin Health, 145 Studley Road, Heidelberg, VIC, 3084, Australia.

Resumen

No abstract available in PubMed .